Teens taking a GLP-1 drug also were less likely to take steroids to manage their asthma, 21% versus 31%, and less likely to need a rescue inhaler, 32% versus 45%
Doctors need to watch patients on GLP-1 for signs of gastroparesis
Patients reported that clinicians offered banal advice assuming that the patients were unhealthy or were not trying to address their weight, and assumed that other health symptoms were due to obesity without a proper medical history or examination [14]
Read More: Ozempic and Other GLP-1s May Have Broader Health Benefits but Greater Risks Promising Results with Caveats The study was both relatively small (clinical trials for medication routinely use hundreds, if not thousands of participants) and relatively short term
Crafted in-house, these capsules deliver similar benefits to commercial injectables like Wegovy and Ozempic by targeting the GLP-1 receptor to regulate appetite, boost insulin production, and support effective weight management
Pancreatic Enzymes: Semaglutide carries a warning regarding pancreatitis risk